Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the Omicron era: A prospective cohort study
Calderón-Parra, Jorge, Gutiérrez-Villanueva, Andrea, Ronda-Roca, Gerard, Jimenez, Maria Luisa Martín, de la Torre, Helena, Ródenas-Baquero, María, Paniura-Pinedo, María, Lozano-Llano, Carla, Pintos-Pascual, Ilduara, Fernández-Cruz, Ana, Ramos-Martínez, Antonio, Muñez-Rubio, Elena
Published in International journal of antimicrobial agents (01.03.2024)
Published in International journal of antimicrobial agents (01.03.2024)
Get full text
Journal Article